Computational Identification of GPR119-Targeted Small Molecules as Potential Therapies for Diabetes Mellitus
<p style="margin-left:9pt; margin-right:0cm">Type 2 diabetes mellitus (T2DM) is a global epidemic, accounting for over 90% of diabetes mellitus cases worldwide, in part due to inadequate treatment options. GPR119 is a protein receptor that stimulates insulin excretion and has the potential to revolutionise current T2DM
Authors
- A. Wang
Publication Details
- Journal
- European Journal of Biomedical and Life Sciences
- Published
- 2025-10-26
- DOI
- https://doi.org/10.29013/ejbls-25-3-30-45
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00